$1.600
+0.235 (+14.70%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de NRSN por análisis de gráficos similares
Alphio's NRSN stock price prediction model matches the current Neurosense Therapeutics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.58 (-1.38%). The 1-week path is $1.59 (-0.38%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Neurosense Therapeutics Ltd?
Neurosense Therapeutics Ltd is currently not a good buy due to significant financial losses and a delayed Phase 3 study. The current price is $1.60, which is far below the analyst target of $3.50 from Roth Capital, indicating potential upside but also high risk. The company's RSI is at 38.737, suggesting it is nearing oversold territory, but the overall trend remains negative with a 5-day change of -19.60%.
NRSN cerró en $1.60 el Friday, tras subir +14.70%
Neurosense Therapeutics Ltd (NRSN) last closed at $1.6, gaining +14.70%. These facts feed the 1-day and 1-week NRSN price prediction above.
Factores de la previsión
Los factores de la previsión de Neurosense Therapeutics Ltd (NRSN) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de NRSN, ordenadas por similitud.
Análisis de estacionalidad de NRSN
Historically the probability of a positive November return for NRSN is 52.27%. May offers the highest probability of a positive month at 82.54%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de NRSN
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.69 | $1.82 | $1.94 | +13.79% |
| Dec 2026 | $2.00 | $2.21 | $2.41 | +38.25% |
En 2026, se proyecta que Neurosense Therapeutics Ltd (NRSN) oscile entre $1.69 y $2.41.
Previsión mensual de Neurosense Therapeutics Ltd para 2026
En Nov de 2026, se proyecta que Neurosense Therapeutics Ltd promedie $1.82, con un mínimo de $1.69 y un máximo de $1.94.
En Dec de 2026, se proyecta que Neurosense Therapeutics Ltd promedie $2.21, con un mínimo de $2.00 y un máximo de $2.41.
Artículos relacionados
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.